FemiClear lands BV and herpes products in Target nationwide

By AI, Created 5:20 PM UTC, May 18, 2026, /AGP/ – FemiClear is expanding into Target stores across the U.S. this April with two intimate health products aimed at bacterial vaginosis and genital herpes symptoms. The launch is designed to make over-the-counter care more visible and easier to shop in a category many consumers find confusing.

Why it matters: - FemiClear’s Target rollout puts intimate health products in a mainstream retail setting where many shoppers already buy wellness items. - The launch could make it easier for consumers to find over-the-counter options for bacterial vaginosis and genital herpes symptoms without navigating a stigmatized category online or in specialty aisles. - FemiClear said the move is meant to reduce barriers tied to access, education and stigma.

What happened: - FemiClear announced that FemiClear for Bacterial Vaginosis (BV) Symptoms and FemiClear for Genital Herpes Symptoms launched in Target stores nationwide in April. - The company said the in-store expansion is part of a broader push to grow retail access to clinically studied intimate health solutions. - Caroline Goodner, FemiClear CEO and co-founder, said the expansion is about helping women find solutions more easily and conveniently.

The details: - FemiClear for BV Symptoms is described as a clinically studied formula made with organic ingredients and designed to provide fast-acting relief from common BV symptoms. - The BV product is said to kill 99% of BV-associated bacteria in lab testing. - FemiClear said 91% of users reported symptoms such as fishy odor, excess discharge and irritation were eliminated. - The BV product is designed to provide relief within 24 hours and requires two doses. - FemiClear for Genital Herpes Symptoms is described as a non-prescription topical solution made with organic ingredients. - The herpes product is intended to soothe itching, burning, pain and discomfort associated with outbreaks. - The herpes product is said to kill 99% of HSV-1 and HSV-2 in lab testing. - FemiClear said 90% of users reported less severe outbreaks after use. - The company said the formulas use naturally derived ingredients and patented technology. - FemiClear said NIQ OmniShopper Panel data shows 82% of current FemiClear shoppers are also Target guests. - Janet Carter Smith, FemiClear vice president of sales, said the Target partnership brings greater visibility, clarity and confidence to the category. - FemiClear’s broader product line also includes solutions for yeast infections and urinary health.

Between the lines: - The launch reflects a retail strategy built around convenience and destigmatization, not just product placement. - FemiClear is leaning on education and simpler shelf messaging to address confusion in categories where consumers may not know what to buy. - The company is also positioning Target as a match for its core customer base, based on overlapping shopper data.

What’s next: - FemiClear said it will keep investing in consumer education alongside retail expansion. - The brand signaled that it wants to make intimate health easier to understand, easier to shop and easier to talk about. - The Target rollout may serve as a model for wider visibility across everyday health and wellness retail channels.

The bottom line: - FemiClear is using Target’s national footprint to push intimate health care into a more familiar, easier-to-shop setting for consumers.